Effectiveness of a Vitamin Mineral Supplement
Information source: The Cooper Institute
Information obtained from ClinicalTrials.gov on December 31, 2007 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Healthy
Intervention: Cooper Complete One-A-Day Vitamin Supplement (Drug)
Phase: Phase 1
Status: Active, not recruiting
Sponsored by: The Cooper Institute Official(s) and/or principal investigator(s): Conrad Earnest, PhD, Principal Investigator, Affiliation: The Cooper Institute
Summary
The goal of the study is to evaluate the effectiveness of a new one-a-day Cooper complete
vitamin supplement with or without a combined omega-3 fatty acid supplement on selected
clinical risk factor measures. Participants taking the Cooper Complete one-a-day vitamin plus
omega-3 fatty acid will have greater improvement in homocysteine, LDL cholesterol, and
C-reactive protein than those taking the other supplements.
Clinical Details
Official title: Effectiveness of a One-a-Day Cooper Complete Vitamin / Mineral Supplement With or Without Omega-3 Fatty Acid Ingestion
Study design: Diagnostic, Randomized, Single Blind, Active Control, Single Group Assignment, Efficacy Study
Primary outcome: homocycsteineLDL cholesterol oxidation rate
Secondary outcome: fasting plasma glucoseC-reactive protein
Detailed description:
Participants will be randomized to 1 of 3 groups: vitamin with omega-3, vitamin w/o omega-3,
or omega-3 alone. They will take the vitamin 12 weeks, after which time they will return for
all laboratory tests. Persons who are currently taking a supplement must undergo a 2-week
washout period before beginning the study. Participants taking the Cooper Complete one-a-day
vitamin plus omega-3 fatty acid will have greater improvement in homocysteine, LDL
cholesterol, and C-reactive protein than those taking the other supplements.
Eligibility
Minimum age: 30 Years.
Maximum age: 70 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
30-70 years of age, maintain current diet and exercise regimen, not currently taking
vitamins or agree to stop for 6 weeks
Exclusion Criteria:
BMI <18. 5 or >34. 9, recent blood donation, elevated blood pressure, cholesterol, or fasting
blood glucose that requires medication, plans to move soon, or pregnant or plans to become
pregnant
Locations and Contacts
The Cooper Institute, Dallas, Texas 75230, United States
Additional Information
Starting date: September 2004
Ending date: March 2006
Last updated: March 30, 2006
|